Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics

Prostate cancer (PCa) is the second most diagnosed cancer in men worldwide. For its screening, serum prostate specific antigen (PSA) test has been largely performed over the past decade, despite its lack of accuracy and inability to distinguish indolent from aggressive disease. Metabolomics has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Ana Rita, Pinto, Joana, Amaro, Filipa, Bastos, Maria de Lourdes, Carvalho, Márcia, Guedes de Pinho, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003702/
https://www.ncbi.nlm.nih.gov/pubmed/33808897
http://dx.doi.org/10.3390/metabo11030181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003702/
https://www.ncbi.nlm.nih.gov/pubmed/33808897
http://dx.doi.org/10.3390/metabo11030181

Ejemplares similares